Medical Management of Cerebral Vasospasm following Aneurysmal Subarachnoid Hemorrhage: A Review of Current and Emerging Therapeutic Interventions
Open Access
- 1 January 2013
- journal article
- review article
- Published by Wiley in Neurology Research International
- Vol. 2013, 1-10
Abstract
Cerebral vasospasm is a major source of morbidity and mortality in patients with aneurysmal subarachnoid hemorrhage (aSAH). Evidence suggests a multifactorial etiology and this concept remains supported by the assortment of therapeutic modalities under investigation. The authors provide an updated review of the literature for previous and recent clinical trials evaluating medical treatments in patients with cerebral vasospasm secondary to aSAH. Currently, the strongest evidence supports use of prophylactic oral nimodipine and initiation of triple-H therapy for patients in cerebral vasospasm. Other agents presented in this report include magnesium, statins, endothelin receptor antagonists, nitric oxide promoters, free radical scavengers, thromboxane inhibitors, thrombolysis, anti-inflammatory agents and neuroprotectants. Although promising data is beginning to emerge for several treatments, few prospective randomized clinical trials are presently available. Additionally, future investigational efforts will need to resolve discrepant definitions and outcome measures for cerebral vasospasm in order to permit adequate study comparisons. Until then, definitive recommendations cannot be made regarding the safety and efficacy for each of these therapeutic strategies and medical management practices will continue to be implemented in a wide-ranging manner.Keywords
Funding Information
- National Institutes of Health (1 KL2 RR 31991-1, 12BGIA8700001)
- American Heart Association (1 KL2 RR 31991-1, 12BGIA8700001)
- Brain Aneurysm Foundation (1 KL2 RR 31991-1, 12BGIA8700001)
This publication has 93 references indexed in Scilit:
- Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trialThe Lancet, 2012
- Guidelines for the Management of Aneurysmal Subarachnoid HemorrhageStroke, 2012
- The Albumin in Subarachnoid Hemorrhage (ALISAH) Multicenter Pilot Clinical TrialStroke, 2012
- Safety and efficacy of sildenafil citrate in reversal of cerebral vasospasm: A feasibility studySurgical Neurology International, 2012
- Effects of a Single Dose of Dantrolene in Patients With Cerebral Vasospasm After Subarachnoid HemorrhageStroke, 2011
- Safety and Feasibility of Long-term Intravenous Sodium Nitrite Infusion in Healthy VolunteersPLOS ONE, 2011
- Neuroprotection in Subarachnoid HemorrhageStroke, 2010
- Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic reviewCritical Care, 2010
- Dantrolene Mediates Vasorelaxation in Cerebral Vasoconstriction: A Case SeriesNeurocritical Care, 2008
- Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trendsJournal of Neurology, Neurosurgery & Psychiatry, 2007